Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Michaud V. Drug Metab Lett. Apr 2010; 4(2): 69-76
Pubmed [1087]
Michaud V. Ther Drug Monit. Dec 2006; 28(6): 779-83
Pubmed [3100]
Michaud, Turgeon. Drug Metab Lett 2010, Apr 1;4(2):69-76 [2594]
Michel MC. Expert Opin Pharmacother. Jan 2004; 5(1): 151-60
Pubmed [13159]
Michels G. Dtsch Med Wochenschr. Jan 2012; 137(4): 131-2
Pubmed [5733]
Michelucci R. Epilepsia. Nov 1996; 37(11): 1107-10
Pubmed [761]
Michielsen PJ. Tijdschr Psychiatr. Jan 2007; 49(9): 655-9
Pubmed [10485]
Mico' U. Int Clin Psychopharmacol. Nov 2011; 26(6): 303-10
Pubmed [10489]
Micov A. Pharmacol Res. Jul 2015; 97: 131-42
Pubmed [9598]
Micuda S. Clin Exp Pharmacol Physiol. Apr 2007; 34(4): 296-303
Pubmed [4495]
Micuda S. Eur J Clin Pharmacol. Oct 2004; 60(8): 583-9
Pubmed [408]
Middle et al. Int J Clin Pharmacol Ther 1995; 33: 304–07 [2157]
Midgley I. Xenobiotica. Jan 1994; 24(1): 79-92
Pubmed [8505]
Midoneck SR. N Engl J Med. Nov 1995; 333(22): 1505
Pubmed [5818]
Miesner AR. Ann Pharmacother. Aug 2016; 50(8): 689-90
Pubmed [7326]
Mifsud EJ. Antiviral Res. Apr 2020; 176: 104751
Pubmed [8568]
Migliardi G. Clin Neuropharmacol. Mar 2007; 30(2): 107-13
Pubmed [2638]
Mignat C. Drug Saf. May 1995; 12(5): 334-47
Pubmed [1718]
Mignot E. Lancet Neurol. Feb 2022; 21(2): 125-139
Pubmed [11782]
Mihara et al. Ther Drug Monit (1997) 19, 43-45 [2381]
Mihara K. Psychopharmacology (Berl). Sep 1997; 133(1): 95-8
Pubmed [10218]
Mijatović V. J Forensic Sci. Sep 2014; 59(5): 1280-5
Pubmed [1267]
Mika J. Pharmacol Rep. Jan 2013; 65(6): 1611-21
Pubmed [12121]
Mikati M et al. Neurology (1990) 40 (Suppl 1), 138 [715]
Mikhail N. Curr Drug Saf. May 2009; 4(2): 121-2
Pubmed [6486]
Mikkaichi T. Drug Metab Dispos. Apr 2014; 42(4): 520-8
Pubmed [4071]
Mikkelsen EJ. Caffeine and schizophrenia. J Clin Psychiatry (1978) 39, 732-5 [853]
Mikus G. Clin Pharmacokinet. Mar 2019
Pubmed [7592]
Mikus G. Clin Pharmacol Ther. Aug 2006; 80(2): 126-35
Pubmed [6424]
Milano G. Clin Psychopharmacol Neurosci. Aug 2017; 15(3): 292-295
Pubmed [11223]
Mildvan D. J Acquir Immune Defic Syndr. Apr 2002; 29(5): 471-7
Pubmed [7130]
Miles FK. Med J Aust. Nov 1999; 171(9): 472-5
Pubmed [11960]
Milic M. Clin Ther. Apr 2006; 28(4): 582-90
Pubmed [13062]
Milinkovic A. Expert Rev Anti Infect Ther. Jun 2004; 2(3): 367-73
Pubmed [7137]
Militaru FC. J Med Life. Apr 2015; 8(2): 171-5
Pubmed , Volltext [9959]
Millan MJ. Psychopharmacology (Berl). Aug 2003; 168(4): 397-409
Pubmed [4095]
Millan MJ. Psychopharmacology (Berl). Feb 2005; 177(4): 448-58
Pubmed [2852]
Millar AB. Genitourin Med. Jun 1990; 66(3): 156-8
Pubmed , Volltext [7280]
Miller AD. Pharmacotherapy. Apr 2011; 31(4): 408-23
Pubmed [7299]
Miller DB. Clin Pharmacokinet. Feb 1998; 34(2): 155-62
Pubmed [276]
Miller DD. Am J Psychiatry. Mar 1983; 140(3): 351-2
Pubmed [13011]
Miller DD. J Clin Psychiatry. Jan 1991; 52(1): 23-5
Pubmed [1182]
Miller DG. J Emerg Med. Jan 2011; 40(1): 25-7
Pubmed [3606]
Miller FA, Rampling D. Adverse effects of combined propanolol and chlorpromazine therapy. Am J Psychiatry (1982) 139, 1189-9 [925]
Miller JL. Am J Health Syst Pharm. Apr 2000; 57(7): 625-6
Pubmed [6888]
Miller KM. Drugs. Feb 2019; 79(3): 291-302
Pubmed [8846]
Miller RG. Cochrane Database Syst Rev. Jan 2002; (2): CD001447
Pubmed [11377]
Miller RR. Chest. Mar 1979; 75(3): 356-8
Pubmed [6793]
Miller S. J Kans Med Soc. Aug 1974; 75(8): 263-4 passim
Pubmed [4867]
Miller SC. J Clin Psychopharmacol. Feb 1997; 17(1): 54-5
Pubmed [1692]
Millson DS. Expert Opin Pharmacother. Mar 2000; 1(3): 391-404
Pubmed [11406]
Milne RW. Pharm Res. Dec 2000; 17(12): 1511-5
Pubmed [8345]
Milner E. J Clin Pharm Ther. May 2022; 47(5): 668-675
Pubmed [12419]
Milner G, Landauer AA. Alcohol, thioridazine and chlorpromazine effects on skills relatd to driving behaviour. Br J Psychiatry (1971) 118, 351-2 [818]
Mimura H. Drug Metab Pharmacokinet. Feb 2015; 30(1): 105-10
Pubmed [8995]
Minamiyama Y. FEBS Lett. Jun 1999; 452(3): 165-9
Pubmed [5048]
Mindikoglu AL. Dig Dis Sci. Feb 2007; 52(2): 598-601
Pubmed [10115]
Minea D. Clin Neuropharmacol. Jul 2001; 24(4): 235-8
Pubmed [10808]
Mineo MC. Pharmacotherapy. Mar 2009; 29(3): 357-61
Pubmed [3462]
Miner P Jr. Clin Drug Investig. Mar 2001; 21(3): 233
Pubmed [5635]
Miners JO. Clin Pharmacokinet. Nov 1989; 17(5): 327-44
Pubmed [8458]
Minocha M. Int J Pharm. Sep 2012; 434(1-2): 306-14
Pubmed [12730]
Minov C. Psychiatr Prax. Nov 2004; 31 Suppl 1: S142-4
Pubmed [3239]
Minton NA. Hum Exp Toxicol. Nov 1991; 10(6): 411-8
Pubmed [8291]
Minushkina LO. Kardiologiia. Jan 2008; 48(3): 20-6
Pubmed [52]
Miodownik C. Clin Neuropharmacol. May 2008; 31(3): 176-9
Pubmed [3892]
Miodownik C. Expert Rev Neurother. Jul 2006; 6(7): 983-92
Pubmed [3545]
Miodownik et al. Clin Neuropharmacol. 2005 Nov-Dec;28(6):295-7 [2501]
Miovic M. Cancer. Oct 2007; 110(8): 1665-76
Pubmed [4025]
Mira JA. Antivir Ther. Jan 2007; 12(8): 1225-35
Pubmed [6696]
Miranda HF. Can J Physiol Pharmacol. May 2004; 82(5): 331-8
Pubmed [8488]
Miranda HF. Drug Res (Stuttg). Oct 2019; 69(10): 572-578
Pubmed [8356]
Miranda HF. Inflammopharmacology. Feb 2017; 25(1): 91-97
Pubmed [9628]
Miranda HF. Pharmacology. Jan 2015; 95(1-2): 59-64
Pubmed [9647]
Mirghani RA. Eur J Clin Pharmacol. Sep 2003; 59(5-6): 423-7
Pubmed [82]
Mirken B. AIDS Treat News. Feb 1997; (No 265): 5
Pubmed [6414]
Mirochnick M. Clin Pharmacol Ther. Jul 2001; 70(1): 24-32
Pubmed [5556]
Mirzakhani H. Anesth Analg. Jul 2013; 117(1): 61-4
Pubmed [7186]
Misaka S. J Clin Pharmacol. Jul 2013; 53(7): 738-45
Pubmed [6165]
Misra DP. Clin Rheumatol. Apr 2020
Pubmed [8926]
Misra LK. S D J Med. Jun 1998; 51(6): 189-93
Pubmed [2232]
Misra PS. Am J Med. Sep 1971; 51(3): 346-51
Pubmed [1828]
Misselbrook GP. Acute Med. Jan 2011; 10(4): 206-8
Pubmed [7816]
Mistry GC. J Clin Pharmacol. Jun 1999; 39(6): 636-42
Pubmed [6885]
Mitarbeiter der AbZ-Pharma GmbH, Fachinformation zu Loperamid AbZ akut 2 mg Hartkapseln, Ulm / Deutschland.Jun 2022 [13396]
Mitarbeiter der Lundbeck GmbH Hamburg/Deutschland, Fachinformation Truxal®, Stand August 2013: Abschnitte 4.5 Wechselwirkungen und 5.2 Pharmakokinetische Eigenschaften.Aug 2013 [13711]
Mitarbeiter der Upjohn EESV, Fachinformation zu Lyrica (TM) Hartkapseln, LD Capelle aan den IJssel / Niederlande.Jul 2022 [13397]
Mitarbeiter und Mitarbeiterinnen von Medice Arzneimittel Pütter GmbH & Co. KG, Iserlohn / Deutschland. . Aug 2013; : 1-8
Pubmed [13775]
Mitarbeiter und Mitarbeiterinnen von Medice Arzneimittel Pütter GmbH & Co. KG, Iserlohn / Deutschland. . Aug 2013; : 1-8
Pubmed [13777]
Mitarbeiter und Mitarbeiterinnen von Medice Arzneimittel Pütter GmbH & Co. KG, Iserlohn / Deutschland. . Aug 2013; : 1-8
Pubmed [13778]
Mitarbeiter und Mitarbeiterinnen von Medice Arzneimittel Pütter GmbH & Co. KG, Iserlohn / Deutschland. . Aug 2013; : 1-8
Pubmed [13779]
Mitarbeiter und Mitarbeiterinnen von Medice Arzneimittel Pütter GmbH & Co. KG, Iserlohn / Deutschland. . Aug 2013; : 1-8
Pubmed [13780]
Bildrechte: © spinetta / Fotolia